1. Home
  2. ANDG vs AVLN Comparison

ANDG vs AVLN Comparison

Compare ANDG & AVLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Andersen Group Inc. Class A Common Stock

ANDG

Andersen Group Inc. Class A Common Stock

N/A

Current Price

$66.70

Market Cap

1.3B

Sector

Real Estate

ML Signal

N/A

Logo Avalyn Pharma Inc. Common Stock

AVLN

Avalyn Pharma Inc. Common Stock

N/A

Current Price

$30.62

Market Cap

1.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ANDG
AVLN
Founded
2002
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.3B
IPO Year
2025
2026

Fundamental Metrics

Financial Performance
Metric
ANDG
AVLN
Price
$66.70
$30.62
Analyst Decision
Buy
Strong Buy
Analyst Count
8
5
Target Price
$61.29
★ $61.80
AVG Volume (30 Days)
411.5K
★ 422.0K
Earning Date
11-12-2026
11-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
★ N/A
N/A
Revenue
★ $838,692,000.00
N/A
Revenue This Year
$18.38
N/A
Revenue Next Year
$18.35
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 14.64
N/A
52 Week Low
$18.12
$22.24
52 Week High
$68.41
$40.17

Technical Indicators

Market Signals
Indicator
ANDG
AVLN
Relative Strength Index (RSI) 67.64 59.75
Support Level $52.10 $25.86
Resistance Level $68.41 $33.32
Average True Range (ATR) 2.53 2.03
MACD -0.14 0.77
Stochastic Oscillator 73.93 76.45

Price Performance

Historical Comparison
ANDG
AVLN

About ANDG Andersen Group Inc. Class A Common Stock

Andersen Group Inc is a provider of independent tax, valuation, and financial advisory services to individuals and family offices, businesses, and institutional clients in the United States. It has strategically expanded its business to build an integrated platform of service offerings that enables the company to solve its clients' complex tax and financial challenges. The company's end-to-end services offerings include: Private Client Services, Business Tax Services, Alternative Investment Funds, and Valuation Services. The firm generates the key revenue from Private Client Services, which provide comprehensive tax and financial services for individuals and families, addressing complex client matters involving multigenerational wealth, charitable giving, and trust and estate planning.

About AVLN Avalyn Pharma Inc. Common Stock

Avalyn Pharma Inc is a clinical-stage biopharmaceutical company developing inhaled medicines to treat rare respiratory diseases, including pulmonary fibrosis and other interstitial lung diseases (ILDs). Its current pipeline is focused on treating pulmonary fibrosis, a life-threatening disease with a median survival of three to five years, which is a significantly shorter prognosis than that observed for many forms of cancer. Its flagship programs include AP01 and AP02, which are inhaled formulations of pirfenidone and nintedanib being developed for conditions such as progressive pulmonary fibrosis and idiopathic pulmonary fibrosis. The company has one operating and reportable segment, which is the business of developing and commercializing targeted therapies for rare lung diseases.

Share on Social Networks: